

Coming to you in the 11th Edition of Biologics Manufacturing Korea 2022, the Korea's most focused bioprocessing-focused, knowledge-sharing conference that provides regional biopharmaceutical industry stakeholders a carefully tailored networking platform for leveraging opportunities for strategic collaboration, and exposure to the latest manufacturing technologies and know-how.
Agenda of the BMK 2022 is built around success stories from korea’s biopharmas as well as the technical expertise from international biopharmas and big pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, advanced bioprocessing technique and antibody production, fill & finish innovation to streamline the operations amongst other crucial themes.
Agenda of the BMK 2022 is built around success stories from korea’s biopharmas as well as the technical expertise from international biopharmas and big pharmas, presentations on the latest manufacturing technologies such as single-use and end-to-end continuous processing for biologics, today’s challenges and opportunities in biomanufacturing, advances in upstream process development, cost-optimization strategies in downstream processing, analytical characterization strategies, advanced bioprocessing technique and antibody production, fill & finish innovation to streamline the operations amongst other crucial themes.
Upstream Processing
Explore the most comprehensive upstream processing for enhancing and optimizing cell culture return and production rate with cost-reduction strategy. Know-how on the latest development of upstream processing technologies have evolved and potentially changed the biologics drug manufacturing process to be more economically feasible.
Downstream Recovery, Product Purification & Viral Clearance
Immerse into various biologics downstream processing techniques with the ultimate goal of meeting quality and purity requirements of biologics drug products. Multiple purification approaches, concentration, product recovery, cost reduction and optimizing the integration of continuous manufacturing and utilization of single use disposable systems to optimize biologics manufacturing process production rate will be discussed.
Fill - Finish Innovation to Streamline Operations
In response to the COVID-19 pandemic, the biologics fill-finish industry has bloomed and reflected on multiple cost-reduction strategies in parenteral lyophilization, formulation and fill-finish strategies. Explore the latest innovation from the Korea biopharma in the fill-finish process and optimize the production line.
Advanced Bioprocessing Technique and Antibody Production
Dive deep into the advancement of bioprocessing techniques for highest productivity and scalability while ensuring cost and time efficiency of Korea's biopharmas.
CMO/CDMO Showcase
From core capabilities including cell line development, process development, analytical method development, find out how to achieve faster and better path to IND filings and successful BLAs with the support from CMO/CDMO.
Present your expertise to the key vaccines stakeholders from developing economies through a variety of available speaking packages.
Join the exhibition, and build an impressive presence among your potential clients.
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
Engage with and build lasting connections that matter the most to your business.
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.